SCHEMBL31599149

SCHEMBL31599149

CC(C)(C)OC(=O)[C@@H](Cc1cccc(Nc2ccc3c(c2)CCC3)c1)[C@H]1CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ USP30 Q70CQ3 1/20 0.46
▸ GPR119 Q8TDV5 7/20 0.42
▸ NOD2 Q9HC29 1/20 0.41
▸ NOD1 Q9Y239 1/20 0.41
▸ MMP9 P14780 1/20 0.39
▸ JAK2 O60674 3/20 0.39
▸ JAK3 P52333 2/20 0.39
▸ PTK2 Q05397 2/20 0.39
▸ JAK1 P23458 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ POLB P06746 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ HTT P42858 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23761152 0.91 USP30 (0.50) USP30GPR119MMP9JAK2JAK1
SCHEMBL31599008 0.90 USP30 (0.47) NPC1RAB9AUSP30GPR119MMP9
SCHEMBL22750409 0.90 USP30 (0.51) USP30GPR119MMP9JAK2JAK1
SCHEMBL23751518 0.90 USP30 (0.51) USP30GPR119MMP9JAK2JAK1
SCHEMBL25957771 0.85 USP30 (0.56) NPC1RAB9AUSP30GPR119MMP9
SCHEMBL30543854 0.85 USP30 (0.56) NPC1RAB9AUSP30GPR119MMP9
SCHEMBL31599077 0.85 USP30 (0.56) NPC1RAB9AUSP30GPR119MMP9
SCHEMBL25958882 0.84 TACR1 (0.46) USP30GPR119MMP9JAK2JAK1
SCHEMBL31291136 0.84 TACR1 (0.46) USP30GPR119MMP9JAK2JAK1
SCHEMBL23761164 0.83 USP30 (0.47) USP30GPR119JAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250171399-A1 PYRROLIDINE COMPOUNDS ELI LILLY AND COMPANY 2025-05-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171399-A1 PYRROLIDINE COMPOUNDS SDHA, GMPS, SDHB NPC1 700/4885RAB9A 230/4885USP30 3650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback